Search Results - "Dizman, N."

SUN-P130: Awareness of Healthcare Professionals and the Status of their Patients in Nutritional Care by Gonen, O, Bozkurt, I, Dizman, N, Oguz, A

Get full text

Comparative effect of body-mass index on outcome with targeted therapy and immunotherapy in patients with metastatic renal cell carcinoma (mRCC) by Dizman, N., Bergerot, P., Bergerot, C.D., Philip, E.J., Salgia, M.M., Hsu, J., Adashek, J., Pal, S.K.

Get full text

Efficacy And Toxicity Of Radiotherapy For Oligoprogression Of Metastatic Renal Cell carcinoma (mRCC) by Dandapani, S.V., Salgia, N., Dizman, N., Zengin, Z.B., Hsu, J., Pal, S.K.

Get full text

Improving the awareness and clinical practices of healthcare professionals by Gonen, O., Erbakan, A., Mesci, B., Dizman, N., Oguz, A.

Get full text

1479P Ultra-sensitive circulating tumor DNA (ctDNA) assay distinguishes partial response (PR) and complete response (CR) with immunotherapy in metastatic renal cell carcinoma (mRCC) by Chehrazi-Raffle, A., Muddasani, R., Dizman, N., Hsu, J., Meza, L., Zengin, Z.B., Malhotra, J., Chawla, N., Lyou, Y.M., Dorff, T., Contente-Cuomo, T., Dinwiddie, D., McDonald, B., Trent, J., Murtaza, M., Pal, S.K.

Get full text

1564MO Characterization of COVID-19 vaccination response by antibody (Ab) titer and T-cell receptor (TCR) sequencing in patients (pts) with advanced genitourinary (GU) cancers by Salgia, S.K., Malhotra, J., Zengin, Z., Meza, L., Ely, J., Hsu, J., Kelley, E., Chehrazi-Raffle, A., Govindarajan, A., Muddasani, R., Salgia, N., Dizman, N., Chawla, N., Dorff, T., Lyou, Y., Karczewska, E., Trent, J., Salgia, R., Altin, J., Pal, S.K.

Get full text

1759MO Associations between sarcopenia and gut microbiota in patients (pts) with metastatic renal cell carcinoma (mRCC) and breast cancer (BC) by Zengin, Z.B., Malhotra, J., Salgia, S.K., Dizman, N., Yost, S., Chawla, N., Govindarajan, A., Hsu, J., Salgia, N., Bergerot, P.G., Meza, L., Chehrazi-Raffle, A., Muddasani, R., Gillece, J., Yuan, Y., Highlander, S., Pal, S.K.

Get full text

Biopsychosocial factors underlying older patients treated for an incurable cancer in a two-tiered health care system in Brazil by Bergerot, C.D., Ashing, K.T., Philip, E., Bergerot, P.G., Dizman, N., Pal, S.K., Dale, W.

Get full text

894PComparative effect of body-mass index on outcome with targeted therapy and immunotherapy in patients with metastatic renal cell carcinoma (mRCC) by Dizman, N, Bergerot, P, Bergerot, C D, Philip, E J, Salgia, M M, Hsu, J, Adashek, J, Pal, S K

Get full text

Impact of race on survival following radical cystectomy for muscle-invasive bladder cancer (MIBC): Analysis of the US National Cancer Database (NCDB) by Dizman, N., Pal, S.K., Nelson, R.A., Hsu, J., Bergerot, P., Nix, J., Sonpavde, G.

Get full text

Association between biopsychosocial distress (BPSD) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) by Bergerot, C.D., Clark, K.L., Ashing, K.T., Almeida, L., Bergerot, P.G., Obenchain, R., Dizman, N., Hsu, J., Maia, M.C., Philip, E., Loscalzo, M., Pal, S.K.

Get full text

Serial genotypic characterization of circulating tumor cells (CTCs) in patients with metastatic castration resistant prostate cancer (mCRPC) undergoing treatment with abiraterone acetate (abi) or enzalutamide (enza) by Dizman, N., Patel, J., He, M., Foulk, B., Smirnov, D.A., Hsu, J., Twardowski, P., Kortylewski, M., Bhargava, V., Jones, J., Pal, S.K.

Get full text